PROG Recorded Big Gain
PROG (PROG:NASDAQ) jumped higher at $1.79, a gain of 17.8%. On Thu, Sep 30, 2021, PROG:NASDAQ touched a New 2-Week High of $1.52. The stock got featured on our News Catalysts scanner on Tue, Sep 21, 2021 at 07:46 AM in the 'PATNERSHIP' category. From Thu, Sep 16, 2021, the stock recorded 30.00% Up Days and 36.36% Green Days
About PROG (PROG:NASDAQ)
Progenity Inc is a biotechnology company. It is engaged in developing and commercializing molecular testing products. The company is translating innovation into precision medicine through diagnostic and therapeutic development platforms based on genomics, proteomics, and microbiomics. The firm generates its revenue from molecular laboratory tests, principally from the sale of Innatal, Preparent, and pathology molecular testing.
Top 10 Gainers:
- PEDEVCO Corp. (PED:NYSEMKT), 42.57%
- Biomerica, Inc. (BMRA:NASDAQ), 38%
- Sierra Metals Inc. (SMTS:NYSEMKT), 35.56%
- ENGlobal Corporation (ENG:NASDAQ), 19.1%
- LGHL (LGHL:NASDAQ), 19.05%
- VEV (VEV:NASDAQ), 18.71%
- BITF (BITF:NASDAQ), 18.35%
- TDH Holdings, Inc. (PETZ:NASDAQ), 17.97%
- PROG (PROG:NASDAQ), 17.76%
- SBTX (SBTX:NASDAQ), 16.93%